Carregant...
COVID-19 and lung cancer: risks, mechanisms and treatment interactions
Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective treatment. Clinical management is largely symptomatic, with organ support in intensive care for critically ill patients. The first...
Guardat en:
| Publicat a: | J Immunother Cancer |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246105/ https://ncbi.nlm.nih.gov/pubmed/32434788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000892 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|